Article
[Mechanism on androgen-independent progression of prostate cancer].
Nihon rinsho. Japanese journal of clinical medicine - 1 May 1997
Shimazaki J, Akakura K, Furuya Y, Ito H
Abstract excerpt
Eighty percent of prostate cancer with metastasis respond to androgen ablasion, showing initial androgen-sensitive growth. However, more than half of responders gradually loses dependency up to 5 years. Animal experiments reveal that loss of androgen sensitivity is attributable to complex reasons; adaptation, paracrine control by other androgen-independent tissues, genetic changes and mutation of androgen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
